Nuveen LLC Takes $10.13 Million Position in National Health Investors, Inc. $NHI

Key Points

• Nuveen LLC has acquired 137,092 shares of National Health Investors, Inc. for approximately $10.1 million, representing a 0.29% ownership stake.
• Analysts have upgraded National Health Investors to a consensus rating of "Buy" with a price target of $85.40, including an upgrade to "overweight" by KeyCorp.
• The company recently announced an increase in its quarterly dividend to $0.92 per share, offering a yield of 4.7%, with a dividend payout ratio of 115.02%.

Nuveen LLC bought a new position in shares of National Health Investors, Inc. (NYSE:NHI - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 137,092 shares of the real estate investment trust's stock, valued at approximately $10,126,000. Nuveen LLC owned 0.29% of National Health Investors at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC grew its stake in National Health Investors by 15.8% during the first quarter. Allspring Global Investments Holdings LLC now owns 3,635 shares of the real estate investment trust's stock worth $268,000 after purchasing an additional 495 shares during the period. Bank of New York Mellon Corp grew its stake in National Health Investors by 5.6% during the first quarter. Bank of New York Mellon Corp now owns 588,871 shares of the real estate investment trust's stock worth $43,494,000 after purchasing an additional 31,451 shares during the period. Wealth Enhancement Advisory Services LLC grew its stake in National Health Investors by 11.0% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 3,611 shares of the real estate investment trust's stock worth $267,000 after purchasing an additional 357 shares during the period. SG Americas Securities LLC acquired a new stake in National Health Investors during the first quarter worth approximately $808,000. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in National Health Investors by 3.3% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 478,900 shares of the real estate investment trust's stock worth $35,372,000 after purchasing an additional 15,497 shares during the period. Institutional investors and hedge funds own 62.51% of the company's stock.

National Health Investors Stock Down 1.4%

NYSE:NHI traded down $1.0790 on Monday, hitting $76.7910. The stock had a trading volume of 155,895 shares, compared to its average volume of 230,533. The business's fifty day moving average is $72.19 and its 200 day moving average is $72.63. The company has a market cap of $3.65 billion, a PE ratio of 24.53, a P/E/G ratio of 3.34 and a beta of 0.73. The company has a quick ratio of 10.91, a current ratio of 10.91 and a debt-to-equity ratio of 0.75. National Health Investors, Inc. has a 52 week low of $65.13 and a 52 week high of $86.13.

National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 6th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.16 by $0.06. National Health Investors had a return on equity of 10.32% and a net margin of 40.97%.The business had revenue of $70.27 million for the quarter, compared to analyst estimates of $86.46 million. During the same quarter in the prior year, the company earned $1.18 earnings per share. The company's quarterly revenue was up 6.7% on a year-over-year basis. On average, equities research analysts expect that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.

National Health Investors Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a $0.92 dividend. This is a boost from National Health Investors's previous quarterly dividend of $0.90. This represents a $3.68 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date is Tuesday, September 30th. National Health Investors's dividend payout ratio is 115.02%.

Analysts Set New Price Targets

Several equities research analysts recently commented on NHI shares. KeyCorp raised National Health Investors from a "sector weight" rating to an "overweight" rating and set a $80.00 target price for the company in a research note on Thursday, July 10th. Truist Financial increased their price target on National Health Investors from $77.00 to $81.00 and gave the stock a "buy" rating in a report on Friday, August 15th. Finally, Wedbush upgraded National Health Investors to a "strong-buy" rating in a report on Wednesday, July 2nd. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $85.40.

National Health Investors Profile

Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.